Gene: RAB5B
Official Full Name: RAB5B, member RAS oncogene familyprovided by HGNC
Gene Summary: Enables GDP binding activity; GTP-dependent protein binding activity; and GTPase activity. Involved in antigen processing and presentation and plasma membrane to endosome transport. Located in endosome and extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08834 | RAB5B Knockout cell line (HeLa) | Human | RAB5B | 1:3~1:6 | Negative | Online Inquiry |
KO08835 | RAB5B Knockout cell line (HCT 116) | Human | RAB5B | 1:2~1:4 | Negative | Online Inquiry |
KO08836 | RAB5B Knockout cell line (HEK293) | Human | RAB5B | 1:3~1:6 | Negative | Online Inquiry |
KO08837 | RAB5B Knockout cell line (A549) | Human | RAB5B | 1:3~1:4 | Negative | Online Inquiry |
RAB5B Gene Knockout Cell Lines are specifically engineered cellular models that have had the RAB5B gene inactivated through precise genetic modification techniques, such as CRISPR/Cas9. RAB5B encodes a member of the RAB protein family, which plays a pivotal role in the regulation of endocytosis, membrane trafficking, and cellular signaling pathways. By knocking out this gene, researchers can effectively study the downstream effects on cellular processes, including vesicle formation, transportation, and the interplay between various intracellular compartments.
The primary function of RAB5B is to mediate early endosomal processes, and its knockout represents a powerful tool for elucidating the mechanisms of cellular trafficking and the dynamics of waste recycling within the cell. In addition, this model provides insights into diseases linked to dysregulated trafficking pathways, such as neurodegenerative disorders, cancer, and infectious diseases where pathogen entry is mediated by endocytosis.
Scientific applications of RAB5B Gene Knockout Cell Lines are substantial, with implications ranging from basic research to therapeutic development. They serve as indispensable platforms for investigating the role of endosomal dysfunction in diseases, testing potential drug candidates, as well as studying gene therapies aimed at restoring normal cellular functions. Their specificity allows researchers to isolate the effects of RAB5B loss in various experimental contexts, providing clearer insights into the molecular basis of pathology.
What sets our RAB5B Gene Knockout Cell Lines apart is the high efficiency of gene editing and the robustness of the resulting cell lines. Unlike conventional knockdown approaches, which can lead to partial and often transient inhibition of gene function, our knockout models provide a permanent solution that ensures consistent and reproducible results. This aspect is crucial for high-throughput screening and validation studies.
For researchers and clinicians alike, these cell lines offer enhanced customization and reliability in experimental design, making them invaluable assets for advancing scientific knowledge and therapeutic innovations. Our company prides itself on a commitment to excellence in the development of cutting-edge biological products, underscored by extensive experience in molecular genetics and cell biology, thus ensuring that our products meet the highest standards of quality and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.